Entera Bio Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Entera Bio Ltd., a foreign private issuer, for the month of August 2020. The filing, dated August 17, 2020, consists solely of a press release (Exhibit 99.1) issued on that date. The registrant is based in Jerusalem, Israel, and files annual reports on Form 20-F.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document serves as a vehicle to incorporate a press release by reference and does not contain a financial statement or quantitative performance data.
Material Changes
The filing text does not provide a clear value regarding material changes versus the prior comparable period. The content is limited to the administrative incorporation of a press release into existing registration statements (Form F-3).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. While the filing incorporates a press release by reference, the specific content of that release is not included in the provided text.
Key Facts for Investor Verification
- The filing is a procedural Form 6-K incorporating a press release dated August 17, 2020, by reference.
- No financial data or operational metrics are present in the provided text.
- Investors must review the attached Exhibit 99.1 (the press release) to understand the specific corporate announcement.
- The document updates registration statements on Form F-3 (Registration Numbers 333-238988 and 333-239843).